Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

News Briefs: 23andMe’s Mea Culpa; FDA Reaches Settlement With J&J; Meaningful Use Delay

Dec 09 2013

Related Content

Questions Remain On Incorporating UDIs Into Health Care System

Nov 27 2013

FDA Comes Down Hard On 23andMe, Putting Consumer-Directed Genetic Testing On Notice

Nov 25 2013

Regulatory News In Brief

Mar 25 2013

Quest Enters Market For BRCA Gene Testing

Oct 21 2013

Prostate Cancer Radiation Comparisons Support IMRT, Question Proton Therapy

Apr 23 2012

Diagnostic Companies Rush To Test Formerly Off-Limit Genes

Jun 24 2013

Exact Sciences Completes Modular PMA For <em>Cologuard</em>

Jun 17 2013

Related Companies

23andMe, Inc.

Johnson & Johnson

Advanced Sterilization Products

Johnson & Johnson

Medyssey

Minaris Regenerative Medicine

Medtronic plc

Respironics, Inc.

AngioDynamics, Inc.

Myriad Genetics, Inc.

Myriad Genetics, Inc.

Laboratory Corporation of America

Quest Diagnostics Incorporated

Biodesix, Inc.

Additional Topics

Legal Issues Regulation Medical Device

More from Legal & IP

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window